RT Journal Article SR Electronic T1 Aerobic Metabolism of Niridazole by Rat Liver Microsomes JF Molecular Pharmacology JO Mol Pharmacol FD American Society for Pharmacology and Experimental Therapeutics SP 1019 OP 1030 VO 16 IS 3 A1 JEFFREY L. BLUMER A1 RAYMOND F. NOVAK A1 SAMUEL V. LUCAS A1 JANNEY M. SIMPSON A1 LESLIE T. WEBSTER, JR. YR 1979 UL http://molpharm.aspetjournals.org/content/16/3/1019.abstract AB The metabolism of the anthelmintic nitroheterocyclic compound niridazole by rat liver was studied under aerobic conditions in vitro. Metabolism was localized to the microsomal fraction. Four metabolites of niridazole were isolated from these microsomal systems by high pressure liquid chromatography. The metabolites were characterized by mass spectrometry and 1H Fourier transform nuclear magnetic resonance spectroscopy as the 4-hydroxy, 5-hydroxy, 4,5-dihydroxy and the 4,5-dehydro derivatives of the imidazolidinone ring; the nitrothiazole portion of niridazole apparently was unaltered. The aerobic metabolism was shown to require O2 and exogenous reducing equivalents (NADPH was more effective than NADH), and to be inhibited by CO, suggesting a cytochrome P-450 catalyzed reaction. Inducers of microsomal cytochrome P-450, phenobarbital and 3-methylcholanthrene, were found to enhance niridazole metabolism. Metabolite profiles varied quantitatively with different inducers. Experiments with individual aerobic metabolites showed precursor-product relationships that are consistent with formation of an epoxide intermediate in the overall metabolic sequence.